Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fotagliptin vs alogliptin vs placebo in type 2 diabetes mellitus
CTR20192469Phase 3Completed
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fotagliptin in type 2 diabetes mellitus (T2DM), sponsored by Shenzhen Salubris Pharmaceuticals Co., Ltd.. Started Jan 2020; status: completed.
02
Drugs
fotagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20192469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192469.